Literature DB >> 35069414

Iron Deposition in Gray Matter Nuclei of Patients With Intracranial Artery Stenosis: A Quantitative Susceptibility Mapping Study.

Huimin Mao1,2, Weiqiang Dou3, Xinyi Wang1, Kunjian Chen1,2, Xinyu Wang1,2, Yu Guo1,2, Chao Zhang1.   

Abstract

Purpose: This study aimed to use quantitative susceptibility mapping (QSM) to systematically investigate the changes of iron content in gray matter (GM) nuclei in patients with long-term anterior circulation artery stenosis (ACAS) and posterior circulation artery stenosis (PCAS).
Methods: Twenty-five ACAS patients, 25 PCAS patients, and 25 age- and sex-matched healthy controls underwent QSM examination. Patients were scored using the National Institutes of Health Stroke Scale (NIHSS) and modified Rankin Scale (mRS) to assess the degree of neural function deficiency. On QSM images, iron related susceptibility of GM nuclei, including bilateral caudate nucleus, putamen (PU), globus pallidus (GP), thalamus (TH), substantia nigra (SN), red nucleus, and dentate nucleus (DN), were assessed. Susceptibility was compared between bilateral GM nuclei in healthy controls, ACAS patients, and PCAS patients. Partial correlation analysis, with age as a covariate, was separately performed to assess the relationships of susceptibility with NIHSS and mRS scores.
Results: There were no significant differences between the susceptibilities for left and right hemispheres in all seven GM nucleus subregions for healthy controls, ACAS patients, and PCAS patients. Compared with healthy controls, mean susceptibility of bilateral PU, GP, and SN in ACAS patients and of bilateral PU, GP, SN, and DN in PCAS patients were significantly increased (all P < 0.05). In addition, mean susceptibility of bilateral TH and SN in PCAS patients was significantly higher than in ACAS patients (both P < 0.05). With partial correlation analysis, mean susceptibility at bilateral PU of ACAS patients was significantly correlated with mRS score (r = 0.415, P < 0.05), and at bilateral PU in PCAS patients was correlated with NIHSS score (r = 0.424, P < 0.05).
Conclusion: Our findings indicated that abnormal iron metabolism may present in different subregions of GM nuclei after long-term ACAS and PCAS. In addition, iron content of PU in patients with ACAS and PCAS was correlated with neurological deficit scores. Therefore, iron quantification measured by QSM susceptibility may provide a new insight to understand the pathological mechanism of ischemic stroke caused by ACAS and PCAS.
Copyright © 2022 Mao, Dou, Wang, Chen, Wang, Guo and Zhang.

Entities:  

Keywords:  anterior circulation artery stenosis; gray matter nuclei; iron deposition; ischemic stroke; posterior circulation artery stenosis; quantitative susceptibility mapping

Year:  2022        PMID: 35069414      PMCID: PMC8766754          DOI: 10.3389/fneur.2021.785822

Source DB:  PubMed          Journal:  Front Neurol        ISSN: 1664-2295            Impact factor:   4.003


  49 in total

Review 1.  The role of transferrins and iron-related proteins in brain iron transport: applications to neurological diseases.

Authors:  Camila Campos-Escamilla
Journal:  Adv Protein Chem Struct Biol       Date:  2020-12-19       Impact factor: 3.507

2.  Normalization of T2 relaxation time and apparent diffusion coefficient in relation to the inflammatory changes in the substantia nigra of rats with focal cerebral ischemia.

Authors:  Yan Mei Yang; Chan Chan Li; Le Kang Yin; XiaoYuan Feng
Journal:  Acta Radiol       Date:  2014-09-26       Impact factor: 1.990

3.  Validation of quantitative susceptibility mapping with Perls' iron staining for subcortical gray matter.

Authors:  Hongfu Sun; Andrew J Walsh; R Marc Lebel; Gregg Blevins; Ingrid Catz; Jian-Qiang Lu; Edward S Johnson; Derek J Emery; Kenneth G Warren; Alan H Wilman
Journal:  Neuroimage       Date:  2014-11-08       Impact factor: 6.556

Review 4.  Quantitative Susceptibility Mapping: Technical Considerations and Clinical Applications in Neuroimaging.

Authors:  Selvadasan Vinayagamani; R Sheelakumari; Sekar Sabarish; Santhakumar Senthilvelan; Roopa Ros; Bejoy Thomas; Chandrasekharan Kesavadas
Journal:  J Magn Reson Imaging       Date:  2020-01-17       Impact factor: 4.813

5.  Patterns of Brain Iron Accumulation in Vascular Dementia and Alzheimer's Dementia Using Quantitative Susceptibility Mapping Imaging.

Authors:  Yeonsil Moon; Seol-Heui Han; Won-Jin Moon
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

6.  New England Medical Center Posterior Circulation Stroke Registry II. Vascular Lesions.

Authors:  Lr Caplan; Rj Wityk; L Pazdera; H-M Chang; Ms Pessin; Ld Dewitt
Journal:  J Clin Neurol       Date:  2005-04-30       Impact factor: 3.077

Review 7.  Iron in chronic brain disorders: imaging and neurotherapeutic implications.

Authors:  James Stankiewicz; S Scott Panter; Mohit Neema; Ashish Arora; Courtney E Batt; Rohit Bakshi
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

8.  Intranasal deferoxamine provides increased brain exposure and significant protection in rat ischemic stroke.

Authors:  Leah R Hanson; Annina Roeytenberg; Paula M Martinez; Valerie G Coppes; Donald C Sweet; Reshma J Rao; Dianne L Marti; John D Hoekman; Rachel B Matthews; William H Frey; S Scott Panter
Journal:  J Pharmacol Exp Ther       Date:  2009-06-09       Impact factor: 4.030

9.  Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study.

Authors:  Christian Langkammer; Ferdinand Schweser; Nikolaus Krebs; Andreas Deistung; Walter Goessler; Eva Scheurer; Karsten Sommer; Gernot Reishofer; Kathrin Yen; Franz Fazekas; Stefan Ropele; Jürgen R Reichenbach
Journal:  Neuroimage       Date:  2012-05-24       Impact factor: 6.556

10.  Implications of the putamen in pain and motor deficits in complex regional pain syndrome.

Authors:  Monica Azqueta-Gavaldon; Andrew M Youssef; Claudia Storz; Jordan Lemme; Heike Schulte-Göcking; Lino Becerra; Shahnaz C Azad; Anselm Reiners; Birgit Ertl-Wagner; David Borsook; Jaymin Upadhyay; Eduard Kraft
Journal:  Pain       Date:  2020-03       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.